|
Basic Characteristics of Mutations
|
|
Mutation Site
|
N501Y |
|
Mutation Site Sentence
|
Quantifying the transmission advantage associated with N501Y substitution of SARS-CoV-2 in the UK: an early data-driven analysis. |
|
Mutation Level
|
Amino acid level |
|
Mutation Type
|
Nonsynonymous substitution |
|
Gene/Protein/Region
|
S |
|
Standardized Encoding Gene
|
S
|
|
Genotype/Subtype
|
- |
|
Viral Reference
|
-
|
|
Functional Impact and Mechanisms
|
|
Disease
|
COVID-19
|
|
Immune
|
- |
|
Target Gene
|
-
|
|
Clinical and Epidemiological Correlations
|
|
Clinical Information
|
- |
|
Treatment
|
- |
|
Location
|
UK |
|
Literature Information
|
|
PMID
|
33506254
|
|
Title
|
Quantifying the transmission advantage associated with N501Y substitution of SARS-CoV-2 in the UK: an early data-driven analysis
|
|
Author
|
Zhao S,Lou J,Cao L,Zheng H,Chong MKC,Chen Z,Chan RWY,Zee BCY,Chan PKS,Wang MH
|
|
Journal
|
Journal of travel medicine
|
|
Journal Info
|
2021 Feb 23;28(2):taab011
|
|
Abstract
|
The emerging N501Y mutation in severe acute respiratory syndrome coronavirus 2, which becomes prevalent in the UK rapidly, is one of the major challenges of COVID-19 control. To explore the transmission advantage, we estimate that the N501Y substitution increases the infectivity by 52% (95% confidence interval: 46, 58) in terms of the reproduction number.
|
|
Sequence Data
|
-
|